Lorenza Torti

604 total citations
18 papers, 402 citations indexed

About

Lorenza Torti is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Lorenza Torti has authored 18 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 9 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in Lorenza Torti's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Kruppel-like factors research (4 papers). Lorenza Torti is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Kruppel-like factors research (4 papers). Lorenza Torti collaborates with scholars based in Italy, United States and Lebanon. Lorenza Torti's co-authors include Luigi Maria Larocca, Luciana Teofili, Maurizio Martini, Tonia Cenci, Giuseppe Leone, Francesco Guidi, Fiorina Giona, Robin Foà, Eugenia Rosa Nuzzolo and Maria Grazia Iachininoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lorenza Torti

15 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorenza Torti Italy 10 301 211 192 99 61 18 402
Giuliana Alimena Italy 13 226 0.8× 261 1.2× 111 0.6× 99 1.0× 44 0.7× 47 429
Tiejun Qin China 15 323 1.1× 471 2.2× 232 1.2× 91 0.9× 60 1.0× 88 599
Eran Zimran Israel 9 137 0.5× 156 0.7× 169 0.9× 35 0.4× 63 1.0× 29 355
Ali Tabarroki United States 10 225 0.7× 448 2.1× 348 1.8× 58 0.6× 60 1.0× 27 679
M Masi Italy 13 105 0.3× 458 2.2× 218 1.1× 89 0.9× 129 2.1× 26 597
Giuseppe Gaetano Loscocco Italy 12 486 1.6× 368 1.7× 253 1.3× 186 1.9× 26 0.4× 51 541
Anna Tasidou Greece 9 102 0.3× 187 0.9× 233 1.2× 67 0.7× 106 1.7× 13 375
Woo‐Sung Min South Korea 14 119 0.4× 323 1.5× 87 0.5× 26 0.3× 104 1.7× 34 451
Emilia Scalzulli Italy 10 159 0.5× 271 1.3× 120 0.6× 52 0.5× 90 1.5× 60 358
Ayalew Tefferi United States 10 455 1.5× 404 1.9× 187 1.0× 162 1.6× 51 0.8× 12 585

Countries citing papers authored by Lorenza Torti

Since Specialization
Citations

This map shows the geographic impact of Lorenza Torti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenza Torti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenza Torti more than expected).

Fields of papers citing papers by Lorenza Torti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenza Torti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenza Torti. The network helps show where Lorenza Torti may publish in the future.

Co-authorship network of co-authors of Lorenza Torti

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenza Torti. A scholar is included among the top collaborators of Lorenza Torti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenza Torti. Lorenza Torti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Torti, Lorenza, et al.. (2024). Luspatercept in β‐thalassemia: Who and when. Strengths and weaknesses points of a real‐world evidence. SHILAP Revista de lepidopterología. 5(6). 1354–1358. 1 indexed citations
2.
Muro, Marianna De, Sergio Amadori, Paolo de Fabritiis, et al.. (2023). Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy. Therapeutic Advances in Hematology. 14. 1564108443–1564108443.
3.
Torti, Lorenza, Francesco Sorrentino, Laura Maffei, Paolo de Fabritiis, & Elisabetta Abruzzese. (2023). Epidemiological surveillance of SARSCov2 in β-Thalassemia Patients in the last two years: reinfection rate, insights and future challenges. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023007–e2023007.
4.
Hokland, Peter, Shahina Daar, Sujit Sheth, et al.. (2023). Thalassaemia—A global view. British Journal of Haematology. 201(2). 199–214. 25 indexed citations
5.
Torti, Lorenza. (2022). Life beyond alpha‐thalassaemia: We are moving forward. British Journal of Haematology. 199(1). 11–13.
6.
Torti, Lorenza, et al.. (2020). Impact of SARS CoV-2 in hemoglobinopathies: a protective mechanism being from Beta chain Hemoglobin defects?. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020052–e2020052. 11 indexed citations
7.
Torti, Lorenza, Stefano Pulini, Anna Morelli, Francesco Bacci, & Paolo Di Bartolomeo. (2016). New Myeloma Diagnostic Criteria: To Treat or Not to Treat? Monocentric Experience of 220 Newly Multiple Myeloma Diagnosed Patients Retrospectively Analyzed. Blood. 128(22). 5629–5629. 1 indexed citations
8.
Torti, Lorenza, Stefano Pulini, Anna Morelli, Francesco Bacci, & Paolo Di Bartolomeo. (2015). Visceral leishmaniasis in relapsed and overtreated multiple myeloma in the era of high dose and “novel agent” therapy. International Journal of Hematology. 102(4). 391–393. 2 indexed citations
9.
Torti, Lorenza, Luciana Teofili, Sara Capodimonti, et al.. (2013). Hypoxia-inducible factor-1α(Pro-582-Ser) polymorphism prevents iron deprivation in healthy blood donors.. PubMed. 11(4). 553–7. 12 indexed citations
10.
Torti, Lorenza, Luigi Maria Larocca, Giuseppina Massini, & Luciana Teofili. (2012). Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012008–e2012008. 5 indexed citations
11.
Teofili, Luciana, Maurizio Martini, Maria Grazia Iachininoto, et al.. (2011). Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms. Blood. 117(9). 2700–2707. 89 indexed citations
12.
Cingolani, Antonella, Lorenza Torti, Carmela Pinnetti, et al.. (2010). Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma. AIDS. 24(15). 2408–2412. 19 indexed citations
13.
Teofili, Luciana, Maria Grazia Iachininoto, Sara Capodimonti, et al.. (2010). Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons. AIDS. 24(16). 2443–2450. 29 indexed citations
14.
Cingolani, Antonella, Lorenza Torti, Carmela Pinnetti, et al.. (2010). Detrimental clinical interaction between ritonavir‐boosted protease inhibitors and vinblastin in HIV‐infected patients with Hodgkin lymphoma. Journal of the International AIDS Society. 13(S4). 1 indexed citations
15.
Teofili, Luciana, Maurizio Martini, Tonia Cenci, et al.. (2008). Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases. International Journal of Cancer. 123(7). 1586–1592. 39 indexed citations
16.
Teofili, Luciana, Fiorina Giona, Maurizio Martini, et al.. (2007). Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia. Journal of Clinical Oncology. 25(9). 1048–1053. 71 indexed citations
17.
18.
Teofili, Luciana, Maurizio Martini, Tonia Cenci, et al.. (2007). Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. Blood. 110(1). 354–359. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuliana Alimena Breakdown of academic impact, for papers by Tiejun Qin Breakdown of academic impact, for papers by Eran Zimran Breakdown of academic impact, for papers by Ali Tabarroki Breakdown of academic impact, for papers by M Masi Breakdown of academic impact, for papers by Giuseppe Gaetano Loscocco Breakdown of academic impact, for papers by Anna Tasidou Breakdown of academic impact, for papers by Woo‐Sung Min Breakdown of academic impact, for papers by Emilia Scalzulli Breakdown of academic impact, for papers by Ayalew Tefferi
Rankless by CCL
2026